glp-1 ra therapy Aesthetic Considerations for Preventing and Managing Receptor Agonist–Related Facial Aging Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for obesity and type 2 diabetes, resulting in rapid or massive weight GLP-1 Receptor Agonists in the

Review findings The review confirms that incretin-based therapies have not only achieved their intended goal of T2D and obesity management but have also demonstrated clinically meaningful benefits across multiple organ systems

GLP-1 is an incretin hormone produced by intestinal L-cells that regulates blood glucose, stimulates insulin secretion, and promotes satiety

You can customize meals based on your needs and lifestyle, and there is enough variety in the rotating menus to keep you from getting bored

It can cause discomfort and affect taste

The Food and Drug Administration also hasnt approved it

doi: 10.1001/jama.293.11.1338 81